Center for Regenerative Medicine of Boston University and Boston Medical Center, Boston, MA 02118, USA; The Pulmonary Center and Department of Medicine, Boston University School of Medicine, Boston, MA 02118, USA.
Penn Center for Pulmonary Biology, University of Pennsylvania, Philadelphia, PA 19104, USA.
Cell Stem Cell. 2017 Oct 5;21(4):472-488.e10. doi: 10.1016/j.stem.2017.08.014. Epub 2017 Sep 28.
Lung alveoli, which are unique to air-breathing organisms, have been challenging to generate from pluripotent stem cells (PSCs) in part because there are limited model systems available to provide the necessary developmental roadmaps for in vitro differentiation. Here we report the generation of alveolar epithelial type 2 cells (AEC2s), the facultative progenitors of lung alveoli, from human PSCs. Using multicolored fluorescent reporter lines, we track and purify human SFTPC+ alveolar progenitors as they emerge from endodermal precursors in response to stimulation of Wnt and FGF signaling. Purified PSC-derived SFTPC+ cells form monolayered epithelial "alveolospheres" in 3D cultures without the need for mesenchymal support, exhibit self-renewal capacity, and display additional AEC2 functional capacities. Footprint-free CRISPR-based gene correction of PSCs derived from patients carrying a homozygous surfactant mutation (SFTPB) restores surfactant processing in AEC2s. Thus, PSC-derived AEC2s provide a platform for disease modeling and future functional regeneration of the distal lung.
肺腺泡是呼吸空气的生物所特有的,从多能干细胞(PSCs)中产生肺腺泡一直具有挑战性,部分原因是可用的模型系统有限,无法为体外分化提供必要的发育路线图。在这里,我们报告了从人类 PSCs 中产生肺泡上皮细胞 2 型(AEC2)的情况,AEC2 是肺腺泡的兼性祖细胞。我们使用多色荧光报告系,追踪和纯化人类 SFTPC+肺泡祖细胞,因为它们在受到 Wnt 和 FGF 信号刺激时从内胚层前体中出现。纯化的 PSC 衍生的 SFTPC+细胞在没有间质支持的情况下在 3D 培养中形成单层上皮“肺泡球体”,表现出自更新能力,并显示出额外的 AEC2 功能能力。基于 CRISPR 的无足迹基因校正可纠正携带表面活性剂突变(SFTPB)的同源纯合子患者的 PSCs,恢复 AEC2 中的表面活性剂处理。因此,PSC 衍生的 AEC2 为疾病建模和远端肺的未来功能再生提供了平台。